A 35 year old male came with jaundice, palpable mass in the right hypochondrium not associated with pain. The probable diagnosis is -
Which of the following statements about Gallbladder carcinoma is true?
Which of the following structures does NOT pass through Calot's triangle?
What is the primary condition treated by the Kasai operation?
What is the standard intercostal space used for hepatic biopsy?
In the Bismuth-Corlette classification, which type involves the hepatic duct confluence WITHOUT extension into secondary intrahepatic ducts?
Pringle's manoeuvre may be required for treatment of
Which of the following is not true about hydatid cysts of the liver?
Which of the following is not a common symptom associated with common bile duct (CBD) stones?
What is the treatment for asymptomatic gallstones greater than 3 cm?
Explanation: ***Pancreatic head carcinoma*** - **Pancreatic head carcinoma** classically presents with **painless progressive jaundice**, which is the hallmark feature of malignant biliary obstruction. - The **palpable mass in the right hypochondrium** represents a **palpable, non-tender gallbladder** known as **Courvoisier's sign** - indicating distal common bile duct obstruction with gallbladder distension. - **Courvoisier's law** states: "A palpable gallbladder in the presence of jaundice is unlikely to be due to stones and suggests malignant obstruction of the biliary tree." - The **absence of pain** is characteristic, as the obstruction develops gradually, unlike acute inflammatory conditions. *Hepatocellular carcinoma* - **Hepatocellular carcinoma (HCC)** can present with a palpable hepatic mass and hepatomegaly in the right hypochondrium. - However, jaundice in HCC is typically a **late feature** occurring with massive liver involvement, extensive hepatic replacement by tumor, or portal vein thrombosis - not early painless jaundice. - HCC more commonly presents with abdominal pain, weight loss, and symptoms of chronic liver disease rather than painless obstructive jaundice. *Acute cholecystitis* - **Acute cholecystitis** presents with severe **right upper quadrant pain** (Murphy's sign positive), fever, and leukocytosis. - The **absence of pain** in this patient makes acute cholecystitis very unlikely. - While a tender palpable gallbladder may be present, painless presentation is not characteristic. *Choledochal cyst* - **Choledochal cysts** can present with the classic triad of **jaundice, abdominal pain, and palpable mass**. - However, they are **more common in children and young females** (80% present before age 10). - The presentation usually includes **episodic abdominal pain** due to recurrent cholangitis or pancreatitis, making the painless presentation less typical. - In a 35-year-old male with painless jaundice, pancreatic malignancy is more likely.
Explanation: ***Gallstones may be a predisposing factor*** - The chronic inflammation and irritation caused by **gallstones (cholelithiasis)** are considered major risk factors for the development of gallbladder carcinoma. - Approximately 70-90% of patients with gallbladder carcinoma also have **cholelithiasis**, suggesting a strong association. *Carries a good prognosis* - Gallbladder carcinoma generally has a **poor prognosis** due to its asymptomatic nature in early stages and aggressive local invasion. - Most cases are diagnosed at an advanced stage, leading to a **low 5-year survival rate**. *Commonly squamous cell carcinoma* - The vast majority of gallbladder carcinomas are **adenocarcinomas** (around 90%), arising from the glandular epithelium. - **Squamous cell carcinoma** is rare, accounting for only a small percentage of cases. *Jaundice is rare* - **Jaundice** is a common symptom in advanced gallbladder carcinoma, often indicating obstruction of the biliary ducts. - It arises when the tumor invades or compresses the **common bile duct**, leading to bilirubin backup.
Explanation: ***Portal vein*** - The **portal vein** is a major vessel that carries venous blood from the gastrointestinal tract and spleen to the liver; it is located within the **porta hepatis** and does not pass through Calot's triangle. - Its position is medial and posterior to the structures within Calot's triangle, making it an unlikely structure to be inadvertently ligated during cholecystectomy. *Cystic artery* - The **cystic artery** is a consistent structure found within Calot's triangle, typically arising from the **right hepatic artery**. - Its presence in the triangle makes it a primary target for ligation during **cholecystectomy**. *Right hepatic artery* - The **right hepatic artery** typically runs **superior to Calot's triangle** and gives off the cystic artery which enters the triangle. - While the right hepatic artery itself does not routinely pass through the triangle, anatomical variations may bring it into close proximity, and it can be at risk of injury during dissection if the critical view of safety is not established. *Lymph node of Lund* - The **lymph node of Lund**, also known as the cystic lymph node, is a key landmark located within Calot's triangle. - Its presence is important for identifying the boundaries of the triangle and assessing for inflammation or malignancy related to the gallbladder.
Explanation: ***Biliary atresia*** - The **Kasai operation**, or **hepatoportoenterostomy**, is the primary surgical treatment for **biliary atresia**, a condition where the bile ducts are blocked or absent. - The procedure aims to establish bile flow from the liver to the small intestine to prevent liver damage. *Choledochal cyst* - A **choledochal cyst** is a congenital dilation of the bile ducts and is typically treated by surgical excision of the cyst and a **Roux-en-Y hepaticojejunostomy**. - While it involves the biliary system, it is a distinct condition from biliary atresia and requires a different surgical approach. *Hepatocellular carcinoma* - **Hepatocellular carcinoma** is a primary liver cancer, and its treatment options range from **surgical resection** and **transplantation** to **chemotherapy** and **radiation**, which are distinctly different from the Kasai operation. - The Kasai operation is not used for malignant conditions of the liver or bile ducts. *Primary biliary cirrhosis* - **Primary biliary cirrhosis** is a chronic autoimmune disease affecting the small bile ducts within the liver, causing progressive cholestasis. - Its management is primarily medical, focusing on symptom control and preventing disease progression with drugs like **ursodeoxycholic acid**, and surgery is not a primary treatment.
Explanation: ***Correct Option: 9th*** - The **9th intercostal space** in the mid-axillary line is the standard and most commonly used entry point for percutaneous liver biopsy. - This location provides safe access to the **right lobe of the liver** while avoiding injury to the **pleura** and **lungs** superiorly and minimizing risk to the **kidney** and other abdominal organs inferiorly. - At this level, the liver is sufficiently large and the approach avoids the pleural reflection, which typically descends to the 8th-9th intercostal space. - Standard surgical textbooks (Sabiston, Schwartz) recommend the **8th-10th intercostal space**, with the 9th being most frequently used. *Incorrect Option: 5th* - The **5th intercostal space** is far too high for liver biopsy and would result in puncturing the **lung** or **pleura**, causing **pneumothorax** or hemothorax. - This space is well above the liver margin and is not suitable for hepatic access. *Incorrect Option: 7th* - While the **7th intercostal space** may occasionally be mentioned, it is generally considered **too high** for routine percutaneous liver biopsy. - This level carries increased risk of **pleural injury** as the pleural reflection may extend to this level, especially during deep inspiration. - It is not the standard or preferred approach in current surgical practice. *Incorrect Option: 11th* - The **11th intercostal space** is too low and significantly increases the risk of injuring the **right kidney** or entering the peritoneal cavity with potential injury to bowel or other abdominal structures. - This space is below the optimal liver access zone and is not recommended for routine liver biopsy.
Explanation: ***Type II*** - This classification specifically describes **cholangiocarcinomas** located at the **hepatic duct confluence** without extension into secondary intrahepatic ducts. - **Type II tumors** involve the hepatic duct confluence but **do not extend** into the right or left secondary intrahepatic ducts. - This is the defining feature that distinguishes Type II from Type III variants. *Type I* - **Type I tumors** are located at least **2 cm distal to the hepatic duct bifurcation**. - This type involves the **common hepatic duct** and **spares the confluence** completely. - Does not meet the criteria of involving the confluence. *Type IIIa* - **Type IIIa tumors** involve the **hepatic duct confluence** with extension into the **right secondary intrahepatic ducts**. - This represents extension **beyond** the confluence, unlike Type II. - The extension into secondary ducts is the key differentiating feature. *Type IIIb* - **Type IIIb tumors** involve the **hepatic duct confluence** with extension into the **left secondary intrahepatic ducts**. - This represents extension **beyond** the confluence, unlike Type II. - The extension pattern differs from Type IIIa by involving the left rather than right system.
Explanation: ***Liver laceration*** - **Pringle's manoeuvre** involves clamping the **hepatoduodenal ligament** to control blood flow to the liver, effectively managing bleeding from **liver lacerations**. - This maneuver helps to differentiate between hepatic and non-hepatic bleeding sources during abdominal surgery. *Injury to tail of pancreas* - An injury to the **tail of the pancreas** is usually managed by surgical resection or repair of the damaged pancreatic tissue, and Pringle's manoeuvre does not directly address this. - The pancreas is supplied by branches of the **celiac axis** and **superior mesenteric artery**, which are not occluded by Pringle's manoeuvre. *Mesenteric ischemia* - **Mesenteric ischemia** is a condition involving reduced blood flow to the intestines via the **mesenteric arteries**; Pringle's manoeuvre would not be an appropriate treatment. - Treatment for mesenteric ischemia typically involves revascularization of the affected mesenteric vessels. *Bleeding esophageal varices* - **Bleeding esophageal varices** are managed by therapies like **endoscopic band ligation**, sclerotherapy, or octreotide infusion. - Pringle's manoeuvre is not indicated for treating bleeding from esophageal varices, as these are related to portal hypertension and not direct hepatic artery/portal vein bleeds.
Explanation: ***Mostly in left lobe*** - **Hydatid cysts** (Echinococcosis) caused by the parasite **Echinococcus granulosus** are most commonly found in the **right lobe of the liver** (75%), followed by the left lobe (15-20%), and then other sites. - The liver is the **primary site** of involvement in around 75% of cases because it is the **first capillary bed** encountered by the swallowed eggs. *Surgical management is done* - **Surgical removal** is often the definitive treatment for **hydatid cysts**, particularly for large, symptomatic, or complicated cysts. - Procedures can range from **cystectomy** (removal of the cyst wall) to **radical resections** depending on the cyst's location and size. *Conservative treatment is effective in elderly with small cyst* - **Conservative management** or "watch and wait" is a viable option for **asymptomatic, small cysts**, especially in **elderly patients** or those with significant comorbidities where surgery might pose a high risk. - **Antiparasitic medications** like **albendazole** are also used, sometimes alone for smaller cysts, or in conjunction with other treatments. *CT shows pathognomonic ring-like calcification* - **Computed tomography (CT)** scans can show characteristic features such as a **"daughter cyst" formation** within the mother cyst or **ring-like calcification** of the cyst wall, which are highly suggestive of a **hydatid cyst**. - While not universally present, the presence of **calcification** is a strong indicator, though the diagnostic gold standard often involves serology and imaging.
Explanation: ***Septic shock*** - While **sepsis** can occur as a complication of **cholangitis** due to CBD stones, **septic shock** itself is a severe, life-threatening systemic response and not a *common symptom* directly associated with the presence of uncomplicated CBD stones. - It represents a late, severe complication of infection rather than an initial or typical presentation. *Pain* - **Biliary colic** due to obstruction of the **cystic duct** or **common bile duct** (CBD) by stones is a very common symptom, manifesting as acute, intense pain in the upper abdomen. - This pain is often felt in the **right upper quadrant** or epigastrium and can radiate to the back or shoulder. *Fever* - **Fever** is a common symptom, particularly when **CBD stones** lead to **cholangitis**, an infection of the bile duct. - The obstruction caused by the stone allows bacterial proliferation, leading to inflammation and systemic symptoms like fever. *Jaundice* - **Jaundice** due to **hyperbilirubinemia** is a frequent symptom when a CBD stone obstructs the flow of bile from the liver into the intestine. - This obstruction prevents the excretion of **conjugated bilirubin**, leading to its build-up in the blood and deposition in tissues, causing yellowing of the skin and eyes.
Explanation: ***Laparoscopic cholecystectomy*** - For **asymptomatic gallstones ≥3 cm**, prophylactic cholecystectomy is **recommended** due to significantly increased risk of gallbladder carcinoma - **Large stone size (≥3 cm)** is an established risk factor for malignant transformation of the gallbladder epithelium - Current guidelines recommend **prophylactic surgery** for high-risk features including stones >3 cm, porcelain gallbladder, and gallbladder polyps >10 mm - **Laparoscopic approach** is preferred as it offers minimal morbidity with excellent outcomes *Observation/watchful waiting* - This approach is appropriate for **small to medium-sized asymptomatic gallstones** (<3 cm) where risk of complications is low - However, for stones **≥3 cm**, the increased malignancy risk makes observation inappropriate - Patient should not be left with untreated large gallstones given the oncological risk *Dissolution therapy* - Ursodeoxycholic acid therapy is only effective for **small cholesterol stones** (<1.5 cm) in select non-surgical candidates - **Completely ineffective** for large stones (>1.5 cm) and has high recurrence rates - Not a viable option for 3 cm stones *ERCP* - **Endoscopic retrograde cholangiopancreatography** is used for **common bile duct stones** or biliary obstruction - **Not indicated** for gallstones confined to the gallbladder - Does not address gallbladder pathology or malignancy risk
Liver Anatomy and Physiology
Practice Questions
Benign Liver Lesions
Practice Questions
Liver Abscess
Practice Questions
Hepatocellular Carcinoma
Practice Questions
Metastatic Liver Disease
Practice Questions
Cirrhosis and Portal Hypertension
Practice Questions
Liver Trauma
Practice Questions
Cholelithiasis and Cholecystitis
Practice Questions
Choledocholithiasis
Practice Questions
Biliary Tract Tumors
Practice Questions
ERCP and Its Complications
Practice Questions
Liver Transplantation Basics
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free